Ultimately, the work by Deng et al. (2025) presents future avenues for exploring the role of OSGIN-1 in ovarian cancer tumorigenesis, particularly as a potential therapeutic for enhancing regulated mechanisms of cell death in tumor cells. The gene discussed is OSGIN1; the disease is neoplasm.